The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand

BACKGROUND: Heparin cofactor II (HCII) is a circulating protease inhibitor, one which contains an N-terminal acidic extension (HCII 1-75) unique within the serpin superfamily. Deletion of HCII 1-75 greatly reduces the ability of glycosaminoglycans (GAGs) to accelerate the inhibition of thrombin, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyle, Amanda J, Roddick, Leigh Ann, Bhakta, Varsha, Lambourne, Melissa D, Junop, Murray S, Liaw, Patricia C, Weitz, Jeffrey I, Sheffield, William P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601010/
https://www.ncbi.nlm.nih.gov/pubmed/23496873
http://dx.doi.org/10.1186/1471-2091-14-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601010/
https://www.ncbi.nlm.nih.gov/pubmed/23496873
http://dx.doi.org/10.1186/1471-2091-14-6

Ejemplares similares